Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.14 - $19.14 $252,838 - $319,638
16,700 New
16,700 $257,000
Q1 2022

May 17, 2022

SELL
$20.94 - $27.5 $1.39 Million - $1.83 Million
-66,500 Reduced 40.65%
97,100 $2.35 Million
Q4 2021

Feb 15, 2022

BUY
$16.79 - $27.09 $1.66 Million - $2.68 Million
99,000 Added 153.25%
163,600 $3.82 Million
Q3 2021

Nov 16, 2021

SELL
$15.78 - $24.77 $312,444 - $490,446
-19,800 Reduced 23.46%
64,600 $1.07 Million
Q2 2021

Aug 16, 2021

SELL
$19.4 - $27.42 $8.91 Million - $12.6 Million
-459,400 Reduced 84.48%
84,400 $2.06 Million
Q1 2021

May 18, 2021

BUY
$25.02 - $54.99 $11.7 Million - $25.7 Million
467,700 Added 614.59%
543,800 $14 Million
Q4 2020

Feb 17, 2021

SELL
$41.04 - $56.79 $1.19 Million - $1.64 Million
-28,900 Reduced 27.52%
76,100 $4.07 Million
Q3 2020

Nov 17, 2020

BUY
$36.42 - $57.0 $3.18 Million - $4.98 Million
87,400 Added 496.59%
105,000 $4.33 Million
Q2 2020

Aug 17, 2020

BUY
$39.26 - $52.73 $369,044 - $495,661
9,400 Added 114.63%
17,600 $853,000
Q1 2020

May 15, 2020

SELL
$31.65 - $46.87 $452,595 - $670,241
-14,300 Reduced 63.56%
8,200 $346,000
Q3 2019

Nov 14, 2019

BUY
$22.22 - $44.01 $286,638 - $567,729
12,900 Added 134.38%
22,500 $810,000
Q4 2017

Feb 15, 2018

BUY
$26.84 - $39.14 $257,664 - $375,744
9,600
9,600 $289,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.73B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.